Garzia, C., Nelson, B., Loo, A., Demenagas, N., & Kubin, C. J. (2025). P-2309. Assessment of Risk Factors Associated with Subtherapeutic Posaconazole Levels. Open Forum Infectious Diseases, 12(Supplement_1). https://doi.org/10.1093/ofid/ofae631.2461

Zhalbinova, M. R., Rakhimova, S. E., Kozhamkulov, U. A., Akilzhanov, K. R., Shaimardanov, N. K., Akilzhanova, G. A., Lee, J. H., Pya, Y. V., Bekbossynova, M. S., & Akilzhanova, A. R. (2024). The Impact of Genetic Polymorphism on Complication Development in Heart Failure Patients. Journal of Clinical Medicine, 14(1), 35. https://doi.org/10.3390/jcm14010035

Fabricant, S. A., Abramson, E. L., Hutchings, K., Vien, A., Scherer, M., & Kapadia, S. N. (2024). PICC Your Poison: Resident Beliefs and Attitudes Regarding Discharge Parenteral Antibiotics for Patients Who Inject Drugs. Open Forum Infectious Diseases, 11(7). https://doi.org/10.1093/ofid/ofae364

Adamson, P. B., Echols, M., DeFilippis, E. M., Morris, A. A., Bennett, M., Abraham, W. T., Lindenfeld, J., Teerlink, J. R., O’Connor, C. M., Connolly, A. T., Li, H., Fiuzat, M., Vaduganathan, M., Vardeny, O., Batchelor, W., & McCants, K. C. (2024). Clinical Trial Inclusion and Impact on Early Adoption of Medical Innovation in Diverse Populations. JACC: Heart Failure, 12(7), 1212–1222. https://doi.org/10.1016/j.jchf.2024.02.015

Lee, K. T., Gonzalez, B. D., Geiss, C., Fulton, H. J., Charles, D., Vadaparampil, S. T., Henry, N. L., Jim, H. S. L., Hershman, D. L., Tworoger, S. S., & Gwede, C. K. (2024). Barriers to endocrine therapy adherence: perspectives of Black breast cancer survivors and their providers. Journal of Cancer Survivorship. https://doi.org/10.1007/s11764-024-01574-7

Lattanza, B., Lakhaney, D., Scott, T., Croker-Benn, A., Giordano, M., & Banker, S. L. (2024). Caring for Children With Medical Complexity: A Clinical, Patient-Focused Curriculum. MedEdPORTAL. https://doi.org/10.15766/mep_2374-8265.11380

Theodore, D., Neradilek, M., Gillespie, K., Edupuganti, S., Hinojosa, J. C., Lama, J. R., De La Grecca, R., Davis, A., Mangini, D. J., Andrew, P., Marovich, M., Zwerski, S., Castor, D., Roxby, A. C., Cohen, M., Corey, L., Huang, Y., Karuna, S., & Sobieszczyk, M. E. (2023). 1558. Associations between gender identity and solicited adverse events after passive infusion of VRC01 or placebo in HVTN 704/HPTN 085. Open Forum Infectious Diseases, 10(Supplement_2). https://doi.org/10.1093/ofid/ofad500.1393

Shah, P. (2023). Essential oils: How safe? How effective? The Journal of Family Practice, 72(09). https://doi.org/10.12788/jfp.0672

Woo, J. L., Nash, K. A., Dragan, K., Crook, S., Neidell, M., Cook, S., Hannan, E. L., Jacobs, M., Goldstone, A. B., Petit, C. J., Vincent, R., Walsh-Spoonhower, K., Mosca, R., Kumar, T. K. S., Devejian, N., Kamenir, S. A., Alfieris, G. M., Swartz, M. F., Meyer, D., … Anderson, B. R. (2023). Chronic Medication Burden After Cardiac Surgery for Pediatric Medicaid Beneficiaries. Journal of the American College of Cardiology, 82(13), 1331–1340. https://doi.org/10.1016/j.jacc.2023.06.046

Hijiya, N., Kapoor, S., Hoch, M., Descamps, L., Dasgupta, K., & Cardoso, A. P. T. (2023). PB1980: ASC4KIDS: A MULTICENTER, OPEN-LABEL, PHASE 1B/2 STUDY TO DETERMINE THE DOSE AND SAFETY OF ASCIMINIB IN PEDIATRIC PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE. HemaSphere, 7(S3), e1669755. https://doi.org/10.1097/01.hs9.0000974736.16697.55

Ycaza, M., Keating, C., DiMango, E., Lopez, J., Saroya, T., & McNeill, T. (2022). 52 Participation in interventional drug trials of minority populations at an urban adult cystic fibrosis center. Journal of Cystic Fibrosis, 21, S32. https://doi.org/10.1016/s1569-1993(22)00743-3

Niyongere, J., Welty, T. E., Bell, M. W., Consalvo, D., Hammond, C., Leung, H., Patsalos, P. N., Ryan, M., Suansanae, T., Zhou, D., & Zuellig, H. (2022). Barriers to generic antiseizure medication use: Results of a global survey by the International League Against Epilepsy Generic Substitution Task Force. Epilepsia Open, 7(2), 260–270. Portico. https://doi.org/10.1002/epi4.12583

Hijiya, N., Kapoor, S., Hoch, M., Descamps, L., Bayar, M. A., & Ramscar, N. (2022). PB1903: TRIAL IN PROGRESS: A MULTICENTER, OPEN-LABEL, PHASE IB/II STUDY TO DETERMINE THE DOSE AND SAFETY OF ASCIMINIB IN PEDIATRIC PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE (CML-CP). HemaSphere, 6, 1782–1783. https://doi.org/10.1097/01.hs9.0000850464.45271.b3